609 related articles for article (PubMed ID: 19457065)
1. The amyloid hypothesis for Alzheimer's disease: a critical reappraisal.
Hardy J
J Neurochem; 2009 Aug; 110(4):1129-34. PubMed ID: 19457065
[TBL] [Abstract][Full Text] [Related]
2. On the origin of Alzheimer's disease. Trials and tribulations of the amyloid hypothesis.
Castello MA; Soriano S
Ageing Res Rev; 2014 Jan; 13():10-2. PubMed ID: 24252390
[TBL] [Abstract][Full Text] [Related]
3. Neurovascular unit dysfunction: a vascular component of Alzheimer disease?
Brenner SR
Neurology; 2008 Jan; 70(3):243-4. PubMed ID: 18195273
[No Abstract] [Full Text] [Related]
4. Amyloid-beta immunotherapy for Alzheimer's disease.
Fu HJ; Liu B; Frost JL; Lemere CA
CNS Neurol Disord Drug Targets; 2010 Apr; 9(2):197-206. PubMed ID: 20205640
[TBL] [Abstract][Full Text] [Related]
5. The Y
Matrone C; Iannuzzi F; Annunziato L
Ageing Res Rev; 2019 Jul; 52():120-128. PubMed ID: 31039414
[TBL] [Abstract][Full Text] [Related]
6. In vivo protection by the xanthate tricyclodecan-9-yl-xanthogenate against amyloid beta-peptide (1-42)-induced oxidative stress.
Perluigi M; Joshi G; Sultana R; Calabrese V; De Marco C; Coccia R; Butterfield DA
Neuroscience; 2006; 138(4):1161-70. PubMed ID: 16427207
[TBL] [Abstract][Full Text] [Related]
7. Alzheimer's disease amyloid hypothesis at crossroads: where do we go from here?
Saxena U
Expert Opin Ther Targets; 2010 Dec; 14(12):1273-7. PubMed ID: 21058918
[TBL] [Abstract][Full Text] [Related]
8. Exploring the Potential of Therapeutic Agents Targeted towards Mitigating the Events Associated with Amyloid-β Cascade in Alzheimer's Disease.
Behl T; Kaur I; Fratila O; Brata R; Bungau S
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33050199
[TBL] [Abstract][Full Text] [Related]
9. Role of synaptic activity in the regulation of amyloid beta levels in Alzheimer's disease.
Cheng X; Wu J; Geng M; Xiong J
Neurobiol Aging; 2014 Jun; 35(6):1217-32. PubMed ID: 24368087
[TBL] [Abstract][Full Text] [Related]
10. N-terminus truncated beta-amyloid peptides and C-terminus truncated secreted forms of amyloid precursor protein: distinct roles in the pathogenesis of Alzheimer's disease.
Geddes JW; Tekirian TL; Mattson MP
Neurobiol Aging; 1999; 20(1):75-9; discussion 87. PubMed ID: 10466897
[No Abstract] [Full Text] [Related]
11. [Cholesterol and Alzheimer's disease].
Kálmán J; Janka Z
Orv Hetil; 2005 Sep; 146(37):1903-11. PubMed ID: 16255374
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapy for Alzheimer's disease: rational basis in ongoing clinical trials.
Menéndez-González M; Pérez-Piñera P; Martínez-Rivera M; Muñiz AL; Vega JA
Curr Pharm Des; 2011; 17(5):508-20. PubMed ID: 21375481
[TBL] [Abstract][Full Text] [Related]
13. Amyloid protein and Alzheimer's disease.
Selkoe DJ
Sci Am; 1991 Nov; 265(5):68-71, 74-6, 78. PubMed ID: 1785042
[No Abstract] [Full Text] [Related]
14. Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP/PS1 mice, a model of Alzheimer's disease.
McClean PL; Hölscher C
Neuropharmacology; 2014 Jan; 76 Pt A():57-67. PubMed ID: 23973293
[TBL] [Abstract][Full Text] [Related]
15. Amyloid beta-protein induces the cerebrovascular cellular pathology of Alzheimer's disease and related disorders.
Van Nostrand WE; Davis-Salinas J; Saporito-Irwin SM
Ann N Y Acad Sci; 1996 Jan; 777():297-302. PubMed ID: 8624102
[TBL] [Abstract][Full Text] [Related]
16. Molecular and cellular mechanisms for Alzheimer's disease: understanding APP metabolism.
Zhang YW; Xu H
Curr Mol Med; 2007 Nov; 7(7):687-96. PubMed ID: 18045146
[TBL] [Abstract][Full Text] [Related]
17. Amyloid Beta Hypothesis in Alzheimer's Disease: Major Culprits and Recent Therapeutic Strategies.
Vijayan D; Chandra R
Curr Drug Targets; 2020; 21(2):148-166. PubMed ID: 31385768
[TBL] [Abstract][Full Text] [Related]
18. Amyloid precursor protein transgenic mouse models and Alzheimer's disease: understanding the paradigms, limitations, and contributions.
Kokjohn TA; Roher AE
Alzheimers Dement; 2009 Jul; 5(4):340-7. PubMed ID: 19560104
[TBL] [Abstract][Full Text] [Related]
19. [The beta-amyloid cascade hypothesis: a sequence of events leading to neurodegeneration in Alzheimer's disease].
Kowalska A
Neurol Neurochir Pol; 2004; 38(5):405-11. PubMed ID: 15565529
[TBL] [Abstract][Full Text] [Related]
20. Rationale for peptide and DNA based epitope vaccines for Alzheimer's disease immunotherapy.
Ghochikyan A
CNS Neurol Disord Drug Targets; 2009 Apr; 8(2):128-43. PubMed ID: 19355933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
